• STAY COOL - Black cohosh is an herb that has been used for centuries to soothe menopause symptoms and in particular hot flashes. It is shown to also help with headaches, night sweats, and heart palpitations. It's considered the natural menopause relief supplement
• NATURAL HORMONE BALANCE - Black Cohosh has also been used to ease PMS symptoms and regulate periods. It can relieve mood changes, sleep problems and vaginal dryness
• HIGH POTENCY - Each tablet contains 200 mg of Black Cohosh with 2.5% Triterpene Glycosides, its active compound
• PURITY - Our Herbal Actives Black cohosh is hypoallergenic, gluten-free, vegetarian and vegan. It is also free of artificial colors, preservatives, yeast, wheat, soy, and milk
• QUALITY MANUFACTURING - Our state-of-the-art manufacturing facilities maintain continuous adherence to cGMP compliance, superior standards, and are FDA and NSF registered

• Is Discontinued By Manufacturer ‏ : ‎ No
• Package Dimensions ‏ : ‎ 3.1 x 1.9 x 1.9 inches; 1.59 ounces
• Item model number ‏ : ‎ 7314
• Manufacturer ‏ : ‎ Nature's Plus

Safety Information
In rare cases Black Cohosh has been reported to affect the liver. Discontinue use and consult your healthcare practitioner if you have a liver disorder or develop symptoms of liver trouble, such as abdominal pain, darkened urine or jaundice. Consult your healthcare practitioner if pregnant, nursing or on medication.

Ingredients
Black Cohosh (Cimicifuga racemosa root and rhizome). Other ingredients: Di-calcium phosphate, stearic acid, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate, silica and pharmaceutical glaze.

Directions
As a dietary supplement offering the consistent benefits of exact potency, takeone tablet daily or as recommended by your health care professional.

Legal Disclaimer
Inspected and certified pursuant to Section 704(a)(1) of the Food, Drug and Cosmetics Act [21 U.S.C. 374(a)]1 and/or Part F or G, Title III of the Public Health Service Act [42 U.S.C. 262-264]2. Compliance to NSF GMP Registration Program Requirements of NSF/ANSI 173 Section 8, which includes FMSA and cGMP (21 CFR 111), (21 CFR 117) assessed and confirmed Jan. 19, 2021 by NSF International. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.